Prevalence of GB virus C/hepatitis G virus RNA and anti-E2 glycoprotein antibodies in homosexual men with HIV coinfection. 2000

M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
City Hospital Munich-Schwabing, Academic Teaching Hospital of the Ludwig-Maximilian University Munich, Germany.

BACKGROUND The objective of this cross-sectional, nonrandomized, prospective study was to generate data on the prevalence of GB virus C (GBV-C)/hepatitis G virus (HGV) in a cohort of HIV-infected homosexuals from Munich. METHODS A total of 71 HIV-infected homosexual men were analyzed for prevalence of GBV-C RNA and antibodies to the E2 envelope glycoprotein (E2Ab). 475 healthy volunteer blood donors in southern Bavaria served as a control group. RESULTS The prevalence of GBV-C RNA was 27% (control group: 2.3%) and the prevalence of E2Ab was 35% (control group: 6%). The total prevalence for present and past infection was 62%. The differences between the HIV-infected patients and the control group were significant (p < 0.0001). GBV-C RNA and E2Ab were not detected simultaneously in any serum sample. The E2Ab positive patients were older than the GBV-C RNA positives (mean 46 years versus 39 years, p = 0.0350). The GBV-C RNA and E2Ab negative patients were older than the GBV-C RNA positives (mean 47 years versus 39 years, p = 0.0236). The E2Ab positive patients had suffered sexually transmitted diseases more frequently than the patients negative for markers of GBV-C infection (p = 0.0308). E2Ab positive patients also had higher mean levels of alanine aminotransferase compared to patients without evidence of GBV-C infection (p = 0.0164). 59.4% of all individuals were anti-HBc IgG positive. CONCLUSIONS The data can be interpreted as indirect evidence for sexual transmission of GBV-C.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
January 1999, Transfusion,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
April 1994, Medicina clinica,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
January 1999, Pediatric research,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
November 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
December 2013, Hepatitis monthly,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
March 2000, The Tohoku journal of experimental medicine,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
November 1999, Journal of medical virology,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
April 2006, The Lancet. Infectious diseases,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
October 2012, Antiviral research,
M Wächtler, and A Hofmann, and G Müller, and G Frösner, and H Nitschko, and M Karwat, and I Knetsch, and C Emminger, and D Eichenlaub
July 2011, Journal of viral hepatitis,
Copied contents to your clipboard!